|
|
||||||||
Published online before print June 16, 2005
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

* Department of Cell Biology and Neuroscience, Rutgers, The State University of New Jersey, Piscataway; and
Harbor General Hospital, University of California, Los Angeles, Torrance
1Correspondence: Department of Cell Biology and Neuroscience, Nelson Biological Laboratories, Rutgers, The State University of New Jersey, 604 Allison Road, Piscataway, NJ 08854. E-mail: covey{at}biology.rutgers.edu
Our previous investigation of a patient (pt1) with non-X-linked hyper-immunoglobulin M syndrome revealed a CD40-mediated defect in B cell activation that resulted in low CD23 expression and absence of germ-line transcription and class-switch recombination. These deficiencies were complemented in vitro by a high threshold of sustained signaling through CD40. To further analyze the signaling defect in pt1 B cells, two types of Epstein-Barr virus lymphoblastoid cell lines (LCLs) were generated that either constitutively expressed the viral transforming protein latent membrane protein-1 (LMP1; pt1-LCL) or expressed it under the control of a tet-inducible promoter (pt1-LCLtet). Because LMP1 signals through the CD40 pathway, the pt1-LCL and pt1-LCLtet lines allow comparison of downstream functions in response to either constitutive LMP1 signals or regulated LMP1 and CD40 signals. Immortalized pt1-LCLs were initially CD23lo/CD38hi and reverted to a CD23hi/CD38lo phenotype upon extended growth in culture, suggesting that the CD40 defect was reversed by selection and/or constitutive expression of LMP1. In contrast, pt1-LCLtet cells retained the CD23lo/CD38hi phenotype after extended periods of culture and failed to up-regulate CD23 in response to CD40 signals. Analysis of pt1-LCLtet cells in response to the CD40 signals in the presence or absence of LMP1 revealed that mitogenic activation resulted only from LMP1 and not CD40, indicating a difference in the response of pt1 B cells to these two distinct signals. Together, these data demonstrate that the pt1-LCLtet cells maintain the CD40-related defect and provide a unique approach to study the independent effects of LMP1- and CD40-directed signals.
Key Words: B cell proliferation B cell activation lymphoblastoid signal transduction viral transformation
This article has been cited by other articles:
![]() |
J. F. Porter, S. Vavassori, and L. R. Covey A Polypyrimidine Tract-Binding Protein-Dependent Pathway of mRNA Stability Initiates with CpG Activation of Primary B Cells J. Immunol., September 1, 2008; 181(5): 3336 - 3345. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. T. Lu, F. L. Sinquett, R. L. Dryer, C. Song, and L. R. Covey c-Rel plays a key role in deficient activation of B cells from a non-X-linked hyper-IgM patient Blood, December 1, 2006; 108(12): 3769 - 3776. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |